Hybrid plasmid vectors containing genes encoding nitrile degrading enzymes and methods of producing amides and acids
10 claims: 5 independent, 5 dependent
- 1A recombinant plasmid, comprising:(a) a DNA sequence which is derived from a plasmid of Rhodococcus rhodochrous ATCC 4276, ATCC 14349, ATCC 14348 or IFO 3338, and which confers the plasmid with the ability to replicate and amplify in cells of bacteria belonging to the genus Rhodococcus;(b) a DNA sequence which confers the plasmid with the ability to replicate and amplify in cells of bacteria belonging to Escherichia coli ;(c) a DNA sequence containing a drug resistance gene;and (d) a DNA sequence of one or more genes encoding a nitrile degrading enzyme derived from bacteria belonging to the genus Rhodococcus . wherein the DNA sequence of (a) is not more than 2.6 kb.
Independent claims5
88 paragraphs, as filed
0001The present invention relates to recombinant plasmids containing one or more genes encoding a nitrile degrading enzyme, transformants that are made by transforming bacteria belonging to the genus <i>Rhodococcus</i> or <i>Escherichia</i> with the recombinant plasmids and to methods of producing amides and acids.
0002Microorganisms belonging to the genus <i>Rhodococcus</i> are known to hydrate or hydrolyze nitriles to produce amides or acids (EP Publication No. 0188316, 0204555, and 0348901). In addition, microorganisms belonging to <i>Rhodococcus rhodochrous</i> are known to have a high hydration activity of nitriles (EP Publication No. 0307926). These useful properties of the microorganisms have motivated to develop a host-vector system to utilize bacteria belonging to the genus <i>Rhodococcus .</i> In reality, vectors suitable to host bacteria belonging to the genus <i>Rhodococcus</i> have not been appreciably developed yet. Very few suitable plasmid vectors have been found from <i>Rhodococcus sp.</i> H13-A [J.Bacteriol. <u>170:</u> 638 - 645 (1988)], <i>Rhodococcus erythropolis</i> (<i>rhodochrous</i>) ATCC12674 [Mol.Gen. Genet., <u>211</u>:148 - 154 (1988)] and <i>Rhodococcus rhodochrous</i> ATCC 4276 which was disclosed by the present inventors in Japanese Patent Application No. 270377/1990. The development of novel vectors which are derived from the genus <i>Rhodococcus</i> and industrially useful in culturing microorganisms or in improving the properties of microorganisms, has been awaited.
0003The present inventors have isolated genes encoding nitrile degrading enzymes from bacteria belonging to the genus <i>Rhodococcus</i>, cloned the genes into vectors derived from <i>Escherichia coli</i> and investigated the gene expression in <i>Escherichia coli</i> hosts. The enzymes having a sufficient enzymatic activity have not been produced in <i>Escherichia coli</i> hosts so far [Eur.J.Bichem. <u>181</u>: 563 - 570 (1989), Biochem.Biophys.Acta., <u>1088</u>: 225 - 233 (1991)].
0004Industrially useful, covalently closed circular plasmids derived from bacteria belonging to the genus <i>Rhodococcus</i> are potentially suitable plasmids to genetically improve the desirable properties of the genus <i>Rhodococcus</i> hosts. These plasmids, however, do not contain drug resistance genes to be used as a marker. Suitable plasmid vectors could be constructed by introducing a marker gene into the plasmids. There is a single example that is described in J. Bacteriol. <u>170:</u> 638 - 645, 1988.
0005We have successfully constructed shuttle vectors suitable for industrial use by inserting drug resistance genes to be used as a marker, cloning sites and genes necessary for replication in <i>Escherichia coli</i> into covalently closed circular plasmids such as pRC001, pRC002. pRC003 and pRC004. We have subsequently subcloned the gene of a clone encoding a nitrile degradation enzyme into the shuttle vectors to give recombinant plasmids, transformed bacteria belonging to the genus <i>Rhodococcus</i> or <i>Escherichia</i> with the recombinant plasmids and produced amides and acids using the transformants.
0006The present invention relates to a recombinant plasmid comprising <ul id="ul0001" list-style="none" compact="compact"><li>(A) a DNA sequence which is derived from a plasmid of Rhodococcus rhodochrous ATCC 4276, ATCC 14349, ATCC 14348 or IFO 3338 and which confers the plasmid the ability to replicate and amplify in the cells of bacteria belonging to the genus <i>Rhodococcus</i>, and</li><li>(B) a DNA sequence which confers the plasmid the ability to replicate and amplify in the cells of bacteria belonging to <i>Escherichia coli</i>,</li><li>(C) a DNA sequence containing a drug resistance gene, and</li><li>(D) a DNA sequence of one or more genes encoding a nitrile degrading enzyme derived from bacteria belonging to the genus <i>Rhodococcus</i>,</li></ul> wherein the DNA sequence of (A) is not more than 2.6 kb.
0007The recombinant plasmids are useful for culturing microorganisms belonging to the genus <i>Rhodococcus</i> or <i>Escherichia</i> to be industrially used and for improving the properties of the microorganisms.
0008The present invention provides transformants that contain the recombinant plasmids of the invention capable of converting nitriles to amides and acids so that the method of the present invention is more efficient in producing amides and acids than conventional methods.
0009Fig. 1 shows a restriction map of pRC001, pRC002. pRC003 or pRC004.
0010Fig. 2 shows a construction of pK1, pK2, pK3, and pK4.
0011Fig. 3 shows a construction of pA3.
0012Fig. 4 shows a construction of recombinant plasmid pKRNH2.
0013Fig. 5 shows a construction of recombinant plasmid pAKR325.
0014The isolated DNA sequence that confers plasmid vectors the ability to replicate and amplify in the cells of bacteria belonging to the genus <i>Rhodococcus</i> is a whole or a part of plasmid selected from the group consisting of pRC001, pRC002. pRC003 and pRC004.
0015pRC001, pRC002. pRC003 and pRC004 are derived from <i>Rhodococcus rhodochrous</i> ATCC4276, ATCC14349, ATCC14348 and IFO3338, respectively. The restriction map of these plasmids is shown in Fig. 1.
0016The isolated DNA sequence that confers plasmid vectors the ability to replicate and amplify in the cells of bacteria belonging to <i>Escherichia</i> coli may be a whole or a part of plasmid selected from the group consisting of pHSG299, pHSG298, pUC19 and pUC18.
0017Suitable marker genes which are expressed in hosts such as bacteria belonging to the genus <i>Rhodococcus</i> and the genus <i>Escherichia</i> and capable of conferring the hosts drug resistance may be a kanamycin resistange gene or a ampicillin resistance gene. Any drug resistance genes or more than one drug resistance gene may be incorporated into plasmid vectors as a marker as long as the presence of the desired plasmid is indicated by the marker.
0018Host bacteria for the hybrid plasmid vectors of the present invention may be <i>Rhodococcus rhodochrous</i> ATCC12674 in the genus <i>Rhodococcus</i> and <i>Escherichia coli</i> K-12 strains in the genus <i>Escherichia</i>. These bacteria can be transformed with the hybrid plasmid vectors.
0019The recombinant plasmid of the present invention comprises hybrid plasmid vectors such as pK1, pK2, pK3, pK4 and pA3. <i>Rhodococcus rhodochrous</i> ATCC12674 was transformed with the hybrid plasmid vectors. The transformants were deposited with Fermentation Research Institute, Agency of Industrial Science and Technology and were assigned the accession number as follows: <tables id="tabl0001" num="0001"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">accession number</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK1</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3728</entry></row><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK2</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3729</entry></row><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK3</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3730</entry></row><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK4</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3731</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pA3</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3732</entry></row></tbody></tgroup></table></tables>
0020Genes encoding nitrile degradation enzymes may be nitrile hydratase and/or amidase genes.
0021Any medium components used to grow microorganisms may be used to culture the transformants. Such medium components include carbon sources such as saccharides, e.g., glucose, fructose, sucrose, maltose, organic acids such as acetic acid and citric acid, alcohols such as ethanol and glycerol, natural nitrogen source such as peptone, meat extract, yeast extract, hydrolyzed proteins, and amino acids, and various inorganic or organic ammonium salts and, if necessary, inorganic salts, a trace amount of metal salts, and vitamines.
0022Microorganisms described above are cultured by methods known in the art: pH 4 - 10, at 20 - 45 °C, aerobic conditions, 10 - 96 hours of incubation. Transformants obtained from culture are used to convert nitrile to amide or acid by the following methods; substrates are added to the suspension of the bacterial cells harvested by centrifugation of the culture; substrates are added to the suspension of the treated bacterial cells (e.g., disrupted bacterial cells, a crude or purified enzyme extract and the like), or to the immobilized bacterial cells by methods known in the art; substrates are added to the culture of the transformants while they grow.
0023Nitriles used as substrates are represented by the general formula, R-(CN)n, wherein n is 1 (mononitrile) to more than 2 (polynitrile), R is hydrogen, saturated or unsaturated hydrocarbon residues having various numbers of a carbon atom in a straight chain, a branched chain, or a cyclic form, an amino group, an hydroxyl group, halogen, a carboxyl group, or hydrocarbon residues having substituents. Nitriles include a wide range of compounds, such as acetonitrile, propionitrile, n-butyronitrile, isobutyronitrile, n-valeronitrile, acrylonitrile, methacrylonitrile, benzonitrile, cyanopyridine, malononitrile, succinonitrile, fumaronitrile, chloroacetonitrile, β-hydroxypropionitrile, aminoacetonitrile and β-aminopropionitrile and the like. Reaction is typically carried out by the conditions: concentration of a substrate; 0.1 - 10 (w/v)%, concentration of a bacterial cell density in culture; 0.01 - 10 (w/v)%, pH 4 - 10.
0024The present invention will be further illustrated by the Examples, which do not limit the scope of the present invention.
Example 1
(1) Construction of Hybrid Plasmid Vectors, pK1, pK2, pK3, and pK4 by Combining pRC001, pRC002, pRC003 or pRC004 with pHSG299,
0025Hybrid plasmid vectors, pK1, pK2, pK3, and pK4, were constructed as is shown in Fig. 2. The DNAs of pRC001, pRC002, pRC003 and pRC004, 1 µg each, were digested with restriction enzyme, ClaI (5 units), at 37°C for one hour. 0.5 µg of pHSG299 DNA(TAKARA SHUZO CO., LTD), which is 2.7kb in size and kanamycin resistant, was digested with 5 units of AccI at 37°C for one hour. After digestion, 1/10 volume of 1M Tris-HCl/pH9.0 was added to both reaction mixtures, which were then dephosphorylated with 1 unit of alkaline phosphatase at 65°C for one hour. The dephosphorylated restriction fragments were electrophoresed along with HindIII digested λ phage DNA as a marker on a 0.7% agarose gel. After electrophoresis, the 2.6kb bands of pRC001, pRC002, pRC003 and pRC004 and the 2.7kb band of pHSG299 were cut out from the gel. DNA was recovered using Gene Clean Kit (FUNAKOSHI K.K.) and dissolved in TE buffer (10mM Tris-HCl, 1mM EDTA, pH8.0). Each of pRC001, pRC002, pRC003 or pRC004 DNA solution was combined with an equal amount of a pHSG299 DNA solution. T4 DNA ligase, ATP, dithiothreitol and MgCl<sub>2</sub> were added to the mixtures ( final concentration in a mixture:1 unit of T4 DNA ligase, 1mM ATP, 10 mM dithiothreitol and 10 mM MgCl<sub>2</sub> ). The ligation mixture was the incubated at 4°C overnight. After incubation, the ligation product was added to the suspension of <i>Escherichia coli</i> JM105 competent cells (TAKARA SHUZO CO., LTD) and the mixture was incubated on ice for one hour. The mixture was heat-shocked at 42°C for 2 minutes and a 2xYT medium (0.5% NaCI, 1% yeast, 1.6% tryptone) was added to the mixture. The mixture was then incubated with shaking at 37°C for one hour. After incubation, the mixture was spread on a 2xYT agar plate containing 1mM IPTG (isopropyl-β-galactoside) and 0.02% X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside). The plate was incubated at 37°C overnight. Colonies were grown on the plate. White colonies were picked and grown in 3 ml of a 2xYT medium containing 50 µg/ml of kanamycin at 37°C for 8 hous. After growth, bacterial cells were harvested by centrifugation at 15,000 rpm for 5 minutes. The bacterial cells were then suspended in 0.35 ml of a STET solution (8% sucrose, 0.5% Triton X-100, 50 mM EDTA, 10 mM Tris-HCl, pH8.0). 25 µl of lysozyme (10 mg/ml) was added to the suspension. The suspension was vortexed for 3 seconds, placed in a boiled water bath for 50 seconds and centrifuged at 15,000 rpm for 15 minutes. The supernatant was saved. 0.5 ml of 1: 1 TE-saturated phenol/chloroform was added to the supernatant. The mixture was vortexed and then centrifuged at 15,000 rpm for 5 minutes. The top portion was saved. 0.5 ml of diether was added to the top portion and the mixture was vortexed. The mixture was then centrifuged and the top portion was discarded. 0.5 ml of isopropanol and 50 µl of 2.5 M acetic acid soda/pH 4.5 were added to the bottom portion. The mixture was incubated at -80 °C for 30 minutes. After incubation, the mixture was centrifuged at 15,000 rpm for 10 minutes. The pellet was rinsed with 70% ethanol, vaccuum dried and resuspended in 0.1 ml of TE buffer. The DNA solution was digested with HindIII, BamHI, SphI, EcoRI and XhoI and a restriction map was constructed. The hybrid plasmids constructed from pRC001, pRC002, pRC003 and pRC004 and pHSG299 were termed pK1, pK2, pK3, and pK4.
0026These plasmids have identical restriction sites as is shown in Table 1. <tables id="tabl0002" num="0002"><table frame="all"><title>Table 1</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col4" align="center">Hybrid plasmids (pK1, pK2, pK3, pK4)</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Restriction enzyme</entry><entry namest="col2" nameend="col2" align="center">Number of sites</entry><entry namest="col3" nameend="col4" align="center">Molecular weight (kb)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">EcoRI</entry><entry namest="col2" nameend="col2" align="center">1</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">5.3</entry></row><row><entry namest="col1" nameend="col1" align="left">BamHI</entry><entry namest="col2" nameend="col2" align="center">2</entry><entry namest="col3" nameend="col3" align="char" char=".">4.4</entry><entry namest="col4" nameend="col4" align="char" char=".">1.0</entry></row><row><entry namest="col1" nameend="col1" align="left">ClaI</entry><entry namest="col2" nameend="col2" align="center">1</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">5.3</entry></row><row><entry namest="col1" nameend="col1" align="left">HindIII</entry><entry namest="col2" nameend="col2" align="center">2</entry><entry namest="col3" nameend="col3" align="char" char=".">3.3</entry><entry namest="col4" nameend="col4" align="char" char=".">2.0</entry></row><row><entry namest="col1" nameend="col1" align="left">SphI</entry><entry namest="col2" nameend="col2" align="center">2</entry><entry namest="col3" nameend="col3" align="char" char=".">3.6</entry><entry namest="col4" nameend="col4" align="char" char=".">1.7</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">XhoI</entry><entry namest="col2" nameend="col2" align="center">1</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">5.3</entry></row></tbody></tgroup></table></tables>
(2) Isolation and Purification of Hybrid Plasmids, pK1, pK2, pK3, and pK4
0027The kanamycin resistance transformants [<i>Escherichia coli</i> JM105 (pK1), <i>Escherichia coli</i> JM105 (pK2), <i>Escherichia coli</i> JM105 (pK3), <i>Escherichia coli</i> JM105 (pK4)] were grown in 200 ml of a 2xYT medium. After growth, bacterial cells were harvested by centrifugation, washed with 40 ml of TES buffer (10 mM Tris-HCl/pH 8.0, 10mM NaCl, 1 mM EDTA) and resuspended in 8 ml of a STET solution (50 mM Tris-HCl/pH8.0, 5 mM EDTA, 35 mM sucrose). 10 mg of lysozyme was added to the suspension and the mixture was shaked at 0°C for 5 minutes. 4 ml of 0.25 M EDTA/pH8.0 was added to the mixture. The mixture was then incubated at 0°C for 5 minutes with occasional gentle swirling. The mixture was then left standing at room temperature. 2 ml of 10% SDS (sodium dodecyl sulfate) and 5 ml of 5 M NaCl were added to the mixture. The mixture was incubated at 4°C for 3 - 12 hours. After incubation, the mixture was centrifuged at 65,000 X g at 4°C for one hour. 4.6 ml of 50% polyethylene glycol (6,000) was added to the supernatant. The mixture Was incubated on ice for 3 hours. The mixture was then centrifuged at 1,000 X g for 5 minutes. The pellet was resuspended in 7.5 ml of TES. 8.2 g of CsCl and 0.2 ml of ethidium bromide (15 mg/ml) was added to the suspension. The mixture was subjected to density gradient centrifugation at 130,000 X g for 42 hours. After centrifugation, the plasmid portion was removed under the irradiation of UV light. The plasmid portion was extracted with n-butanol to remove ethidium bromide. The plasmid extract was dialyzed against TE. Plasmid DNA was precipitated with ethanol. The presence of the desired plasmid DNA was confirmed by electrophoresis on a 0.7% agarose gel.
(3) Introduction of Hybrid Plasmids, pK1, pK2, pK3, and pK4 into bacteria belonging to the genus
Rhodococcus
0028The bacteria cells of <i>Rhodococcus rhodochrous</i> ATCC 12674 at a log phase in growth were harvested by centrifugation, washed 3 times with ice cold sterilized water and resuspended in a 15% PEG(6,000) solution (cell density: more than 10<sup>9</sup>cells/ml). The hybrid plasmid DNAs, 0.01 µg each, were combined with 10 µl of the bacterial cell suspension. The mixture was incubated on ice and then placed in the chamber 11 of a cell fusion apparatus (SHIMAZU Corp., SSH-1). The chamber was cooled and the mixture was subjected to electroporation at a pulse amplitude of 500 µs at an electric field strength of 14kv/cm.
0029After electroporation, the mixture was incubated at 0°C for 10 minutes and then at 37°C for 5 minutes. After incubation, 1 ml of an MY medium was added to the mixture. The mixture was incubated at 25°C for 3 hours. The mixture was then spread on an MY agar medium plate containing 50 µg/ml of kanamycin. The plate was incubated at 25°C for 3 - 6 days. After incubation, colonies were appeared on the plate. These colonies were spread on an MY agar medium plate containing 50 µg/ml of kanamycin again to confirm that the colonies were kanamycin resistant.
0030Transformants, each transformed with pK1, pK2, pK3, or pK4, were deposited with Fermentation Research Institute, Agency of Industrial Science and Technology, and were assigned the following accession numbers; <tables id="tabl0003" num="0003"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">accession number</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK1</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3728</entry></row><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK2</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3729</entry></row><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK3</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3730</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pK4</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3731</entry></row></tbody></tgroup></table></tables>
0031The properties of pK4 are further investigated as described below.
(4) Isolation and Purification of the Hybrid Plasmid Vector from the
Rhodococcus
Transformant
0032<i>Rhodococcus rhodochrous</i> ATCC 12674/pK4 was grown in 400 ml of an MY medium containing 50 µg/ml of kanamycin. When the OD<sub>660</sub> of the culture reached at 0.15 - 0.2, 0.5 U/ml of penicillin G was added to the culture. The culture was further incubated until the OD<sub>660</sub> of the culture reached at 1.0. Bacterial cells were harvested by centrifugation, washed with 40 ml of TES and resuspended in 11 ml of a solution (50 mM of Tris-HCl/pH8.0, 12.5% sucrose, 100mM NaCI, 1mg/ml of lysozyme). The suspension was incubated with shaking at 37°C for 3 hours. 0.6 ml of 0.5 M EDTA, 2.4 ml of 5 M NaCl and 4.4 ml of 4% SDS - 0.7M NaCI were added to the suspension in this order. The mixture was gently swirled and incubated on ice for 18 hours. The mixture was centrifuged at 65,000 X g for at 4°C one hour. After centrifugation, 4.6ml of 50% polyethylene glycol was added to the supernatant. The mixture was incubated on ice for 3 hours. The mixture was then centrifuged at 1,000 X g for 5 minutes. The pellet was resuspended in 5 ml of TES. 7.5 g of CsCI and 2 ml of TES containing 1.5 mg/ml of ethidium bromide were added to the suspension. The mixture was subjected to density gradient centrifugation at 130,000 X g for 42 hours. After centrifugation, plasmid portion was removed under the irradiation of UV light. The plasmid portion was extracted with n-butanol to remove ethidium bromide. The plasmid extract was dialyzed against TE. Plasmid DNA was precipitated with ethanol. The presence of desired plasmid DNA was confirmed by electrophoresis on a 0.7% agarose gel.
(5) Comparison between pK4s isolated from the genus
Escherichia
and
Rhodococccus
(5)-(i) Molecular Weight
0033A small amount of the plasmid DNAs was electrophoresed along with markers such as pUC18 (2.69kb), pUC118 (3.16kb), pBR322 (4.36kb) on a 0.7% agarose gel. The size of both plasmid DNAs was about 5.3kb.
(5)-(ii) Restriction Sites
0034A small amount of the plasmid DNAs was digested with restriction enzymes. The restriction fragments were electrophoresed along with HindIII or PstI digested λ phage DNA as a marker on a 0.7% agarose gel. The band pattern showed that both plasmid DNAs had exactly the same restriction sites as is shown in the Table 1.
(6) Transformation of
Escherichia coli
with pK4 Isolated from
Rhodococcus
0035<i>Escherichia coli</i> JM105 was transformed with pK4 isolated from <i>Rhodococcus rhodochrous</i> ATCC 12674/pK4. Transformants were screened for kanamycin resistance by a 2xYT agar medium plate containing 50 µg/ml of kanamycin. Most of them were positive transformants. Plasmid DNA was isolated from 12 of the positive transformants, digested with restriction enzymes and electrophoresed on a agarose gel. The band pattern showed that the isolated plasmid DNA had the same restriction sites as those isolated from pK4 of the genus <i>Rhodococcus</i> transformant.
Example 2
0036Plasmid pA3 was constructed as is shown in Fig. 3. pRC003 DNA was digested with ClaI and the restriction fragment was inserted into the AccI site of pUC19. The construct was designated as pA3. <i>Escherichia coli</i> JM105 was transformed with pA3 as described in the Example 1. The transformants were screened by a 2xYT agar medium plate containing 50 µg/ml of ampicillin, 1mM IPTG and 0.2% X-gal. White colonies were picked and grown. Plasmid DNA was isolated, purified, digested with restriction enzymes and analyzed. <i>Rhodococcus rhodochrous</i> ATCC 12674 was transformed with the plasmid DNA. The transformant showed that the plasmid DNA conferred ampicillin resistance (10 µg/ml of ampicillin) to the host.
0037The transformant, <i>Rhodococcus rhodochrous</i> ATCC 12674/pA3, was deposited with Fermentation Research Institute, Agency of Industrial Science and Technology, and was assigned the accession number FERM BP-3732.
0038Table 2 shows a restriction enzyme map of pA3. <tables id="tabl0004" num="0004"><table frame="all"><title>Table 2</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col4" align="center">(pA3)</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Restriction enzyme</entry><entry namest="col2" nameend="col2" align="center">Number of sites</entry><entry namest="col3" nameend="col4" align="center">Molecular weight (kb)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">EcoRI</entry><entry namest="col2" nameend="col2" align="center">1</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">5.3</entry></row><row><entry namest="col1" nameend="col1" align="left">BamHI</entry><entry namest="col2" nameend="col2" align="center">2</entry><entry namest="col3" nameend="col3" align="char" char=".">4.3,</entry><entry namest="col4" nameend="col4" align="char" char=".">1.0</entry></row><row><entry namest="col1" nameend="col1" align="left">ClaI</entry><entry namest="col2" nameend="col2" align="center">0</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">-</entry></row><row><entry namest="col1" nameend="col1" align="left">HindIII</entry><entry namest="col2" nameend="col2" align="center">1</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">5.3</entry></row><row><entry namest="col1" nameend="col1" align="left">SphI</entry><entry namest="col2" nameend="col2" align="center">2</entry><entry namest="col3" nameend="col3" align="char" char=".">3.6,</entry><entry namest="col4" nameend="col4" align="char" char=".">1.7</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">XhoI</entry><entry namest="col2" nameend="col2" align="center">1</entry><entry namest="col3" nameend="col3" /><entry namest="col4" nameend="col4" align="char" char=".">5.3</entry></row></tbody></tgroup></table></tables>
Example 3
(1) Construction of Recombinant Plasmids Containing Nitril Hydratase and Amidase Genes
0039pYUK120 and 121 [Eur. J. Biochem. <u>181</u>: 563-570 (1989)] or pANH101[Biochim. Biophys. Acta <u>1088:</u> 225-233 (1991)], which contain a DNA fragment which is originally derived from <i>Rhodococcus</i> sp. N-774 and cloned into <i>Escherichia coli</i>, comprise a nitrile hydratase gene or an amidase gene, respectively.
(1) - (i) Construction of Recombinant Plasmid pKRNH2
0040pKRNH2 was constructed as is shown in Fig. 4. 1 µg of pYUK120 DNA was digested with SphI and HindIII to give a 4.0kb fragment. 1 µg of pANH101 DNA was digested with PstI and HindIII to give a 4.9kb fragment. 1 µg of pK4 DNA was digested with PstI and EcoRI to give a 2.6kb fragment. 1 µg of pHSG299 DNA was digested with SphI and EcoRI to give a 2.7kb fragment. The digestion reaction was carried out at 37°C for one hour. After digestion, the reaction mixture was electrophoresed on a 0.7% agarose gel. These fragments were recoverd from the gel and purified by Gene Clean Kit (FUNAKOSHI K.K.). An equal amount of a DNA solution was taken from each purified DNA solution and was combined. T4 DNA ligase was then added to the mixture. The ligation reaction was carried out at 4°C for 15 hours.
0041After ligation reaction, the ligation product was used to transform <i>Escherichia coli</i> JM109. Colonies were screened for white colonies by a 2xYT agar plate containing 25 µg/ml of Kanamycin, 1mM IPTG and 0.02% X gal. Positive colonies were incubated with shaking in a 2xYT medium containing Kanamycin at 37°C for 10 hours. Plasmid DNA was isolated from the bacterial cells, digested with restriction enzymes and analyzed. Plasmid thus obtained is designated as pKRNH2.
(1) - (2) Construction of Recombinant Plasmid pAKR325
0042pAKR325 was constructed as is shown in Fig. 5. DNA fragments were prepared and the DNA fragments were combined. T4 DNA ligase was added to the DNA mixture. After ligation reaction, <i>Escherichia coli</i> JM109 was transformed with the ligation product and the transformation mixture was spread on a 2xYT agar plate containing 25 µg/ml of Kanamycin, 25 µg/ml of ampicillin, 1mM IPTG and 0.02% X gal to screen for white colonies. Positive colonies were grown in a 2xYT medium containing ampicillin and Kanamycin. Plasmid DNA was isolated from the bacterial cells, digested with restriction enzymes and analyzed. Plasmid thus obtained is designated as pAKR325.
(2) Transformation of Bacteria Belonging to the Genus
Rhodococcus
with pKRNH2 or pAKR325
0043The bacteria cells of <i>Rhodococcus rhodochrous</i> ATCC 12674 at a log phase in growth was centrifuged, washed 3 times with ice cold sterilized water and resuspended in a 15% PEG(6,000) solution (cell density: more than 10<sup>9</sup>cells/ml). pKRNH2 and pAKR325, 0.01 µg each, were combined with 10 µl of the bacterial cell suspension. The mixture was incubated on ice and then placed in the chamber 11 of a cell fusion apparatus (SHIMAZU Corp., SSH-1). The chamber was cooled and the mixture was subjected to electroporation at a pulse amplitude of 500 µs at an electric field strength of 14kv/cm.
0044After electroporation, the mixture was incubated on ice for 10 minutes and then at 37°C for 5 minutes. After incubation, 1 ml of an MY medium was added to the mixture. The mixture was incubated at 25°C for 3 hours. The mixture was then spread on an MY agar plate containing 50 µg/ml of kanamycin. The plate was incubated at 25°C for 3 - 6 days. After incubation, colonies appeared on the plate. These colonies were spread on an MY agar medium plate containing 50 µg/ml of kanamycin again to confirm that the colonies were kanamycin resistant.
0045Transformants, each transformed with pKRNH2 or pAKR325, were deposited with Fermentation Research Institute, Agency of Industrial Science and Technology, and were assigned the following accession numbers; <tables id="tabl0005" num="0005"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">accession number</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pKRNH2</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3733</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left"><i>Rhodococcus rhodochrous</i> ATCC 12674/pAKR325</entry><entry namest="col2" nameend="col2" align="left">FERM BP-3734</entry></row></tbody></tgroup></table></tables>
(3) Production of amides Using Transformants
0046<i>Rhodococcus rhodochrous</i> ATCC 12674/pKRNH2 (hereafter referred to as ATCC 12674/pKRNH2) and <i>Rhodococcus rhodochrous</i> ATCC 12674/pAKR325 (hereafter referred to as ATCC 12674/pAKR325) were grown in 10 ml of an MY-glycerol medium (1% glycerol, 0.5% polypeptone, 0.3% yeast extract, 0.3% malt extract) containing kanamycin (50 µg/ml) under the fluorescent light at 25°C for 15 - 72 hours. <i>Rhodococcus</i><i>rhodochrous</i> ATCC 12674/pK4 (hereafter referred to as ATCC 12674/pK4) was used as a control. ATCC 12674/pKRNH2, ATCC 12674/pAKR325 and the control were also grown in the same medium as described above plus 0.1% isobutyronitrile + 0.1% isobutylamide as an inducer for nitrile hydratase under the same culture conditions. Bacterial cells were harvested by centrifugation, washed with 50 mM phosphate buffer/pH7.7 and resuspended in 1 ml of 50 mM phosphate buffer/pH7.7. The suspension was placed on ice under the fluorescent light for one hour. 100 µl of the suspension and 0.8 ml of 50 mM phophate buffer were combined and the mixture was then incubated at 20°C for 10 minutes. After incubation, 10 µl of 1 M acrylonitrile was added to the mixture, which was then incubated for 30 minutes. 200 µl of 1N-HCl was added to the mixture to stop the reaction. Nitrile hydratase activity was determined by measuring an amount of acrylonitrile and acrylamide in the reaction mixture using gas chromatography. Table 3 shows the nitrile hydratase activity of the transformants and the control. The specific activity was remarkably increased by the addition of the inducer. <tables id="tabl0006" num="0006"><table frame="all"><title>Table 3</title><tgroup cols="6" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="26.25mm" /><colspec colnum="2" colname="col2" colwidth="26.25mm" /><colspec colnum="3" colname="col3" colwidth="26.25mm" /><colspec colnum="4" colname="col4" colwidth="26.25mm" /><colspec colnum="5" colname="col5" colwidth="26.25mm" /><colspec colnum="6" colname="col6" colwidth="26.25mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col6" align="center">Nitrile hydratase activity</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" rowsep="0" align="center">Bacterial Strain/Plasmid</entry><entry namest="col2" nameend="col2" rowsep="0" align="center">Time (hr)</entry><entry namest="col3" nameend="col4" align="center">Without inducer</entry><entry namest="col5" nameend="col6" align="center">With inducer</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" /><entry namest="col3" nameend="col3" align="center">Growth (OD<sub>630</sub>)</entry><entry namest="col4" nameend="col4" align="center">Specific Activity (U/mg cell)</entry><entry namest="col5" nameend="col5" align="center">Growth (OD<sub>630</sub>)</entry><entry namest="col6" nameend="col6" align="center">Specific Activity (U/mg cell)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" morerows="3" align="left">ATCC 12674 /pK4</entry><entry namest="col2" nameend="col2" align="right">15</entry><entry namest="col3" nameend="col3" align="char" char=".">1.84</entry><entry namest="col4" nameend="col4" align="char" char=".">0.00</entry><entry namest="col5" nameend="col5" align="char" char=".">1.70</entry><entry namest="col6" nameend="col6" align="char" char=".">0.00</entry></row><row><entry namest="col2" nameend="col2" align="right">24</entry><entry namest="col3" nameend="col3" align="char" char=".">4.66</entry><entry namest="col4" nameend="col4" align="char" char=".">0.05</entry><entry namest="col5" nameend="col5" align="char" char=".">2.27</entry><entry namest="col6" nameend="col6" align="char" char=".">0.13</entry></row><row><entry namest="col2" nameend="col2" align="right">48</entry><entry namest="col3" nameend="col3" align="char" char=".">4.56</entry><entry namest="col4" nameend="col4" align="char" char=".">0.10</entry><entry namest="col5" nameend="col5" align="char" char=".">4.30</entry><entry namest="col6" nameend="col6" align="char" char=".">1.15</entry></row><row><entry namest="col2" nameend="col2" align="right">72</entry><entry namest="col3" nameend="col3" align="char" char=".">4.11</entry><entry namest="col4" nameend="col4" align="char" char=".">0.03</entry><entry namest="col5" nameend="col5" align="char" char=".">6.50</entry><entry namest="col6" nameend="col6" align="char" char=".">0.06</entry></row><row><entry namest="col1" nameend="col1" morerows="3" align="left">ATCC 12674 /pKRNH2</entry><entry namest="col2" nameend="col2" align="right">15</entry><entry namest="col3" nameend="col3" align="char" char=".">0.13</entry><entry namest="col4" nameend="col4" align="char" char=".">0.60</entry><entry namest="col5" nameend="col5" align="char" char=".">0.10</entry><entry namest="col6" nameend="col6" align="char" char=".">0.20</entry></row><row><entry namest="col2" nameend="col2" align="right">24</entry><entry namest="col3" nameend="col3" align="char" char=".">0.20</entry><entry namest="col4" nameend="col4" align="char" char=".">1.28</entry><entry namest="col5" nameend="col5" align="char" char=".">0.05</entry><entry namest="col6" nameend="col6" align="char" char=".">25.00</entry></row><row><entry namest="col2" nameend="col2" align="right">48</entry><entry namest="col3" nameend="col3" align="char" char=".">0.25</entry><entry namest="col4" nameend="col4" align="char" char=".">1.60</entry><entry namest="col5" nameend="col5" align="char" char=".">0.07</entry><entry namest="col6" nameend="col6" align="char" char=".">46.60</entry></row><row><entry namest="col2" nameend="col2" align="right">72</entry><entry namest="col3" nameend="col3" align="char" char=".">1.50</entry><entry namest="col4" nameend="col4" align="char" char=".">0.12</entry><entry namest="col5" nameend="col5" align="char" char=".">0.32</entry><entry namest="col6" nameend="col6" align="char" char=".">0.44</entry></row><row><entry namest="col1" nameend="col1" morerows="3" rowsep="1" align="left">ATCC 12674 /pAKR325</entry><entry namest="col2" nameend="col2" align="right">15</entry><entry namest="col3" nameend="col3" align="char" char=".">0.33</entry><entry namest="col4" nameend="col4" align="char" char=".">0.02</entry><entry namest="col5" nameend="col5" align="char" char=".">1.09</entry><entry namest="col6" nameend="col6" align="char" char=".">0.05</entry></row><row><entry namest="col2" nameend="col2" align="right">24</entry><entry namest="col3" nameend="col3" align="char" char=".">2.65</entry><entry namest="col4" nameend="col4" align="char" char=".">0.08</entry><entry namest="col5" nameend="col5" align="char" char=".">2.08</entry><entry namest="col6" nameend="col6" align="char" char=".">4.25</entry></row><row><entry namest="col2" nameend="col2" align="right">48</entry><entry namest="col3" nameend="col3" align="char" char=".">4.85</entry><entry namest="col4" nameend="col4" align="char" char=".">0.13</entry><entry namest="col5" nameend="col5" align="char" char=".">3.15</entry><entry namest="col6" nameend="col6" align="char" char=".">9.01</entry></row><row rowsep="1"><entry namest="col2" nameend="col2" align="right">72</entry><entry namest="col3" nameend="col3" align="char" char=".">3.18</entry><entry namest="col4" nameend="col4" align="char" char=".">0.03</entry><entry namest="col5" nameend="col5" align="char" char=".">5.04</entry><entry namest="col6" nameend="col6" align="char" char=".">0.09</entry></row></tbody></tgroup></table></tables>
(4) Nitrile Hydratase Activities of the Enzyme Encoded by the Gene of Recombinant Plasmid or of Chromosome
(4) - (i) SDS-gel Electrophoresis and Western-blotting
0047Bacterial cells harvested from 10 ml of culture were washed with phosphate buffer and suspended in 1 ml of phosphate buffer. The bacterial cells were sonicated with keeping the tube containing the cells on ice and the disrupted cells were centrifuged at 15,000 rpm for 10 minutes. The supernatant containing a crude extract was used for the experiment described below. A 12.5% SDS-gel was prepared as follows. 15 ml of solution A (29.2 g of acrylamide, 0.8g/100ml of N,N'-methylenebisacrylamide), 9 ml of solution B (1.5M Tris-HCl/pH 8.8, 0.4% SDS) and 12 ml of distilled water were combined and the separating gel solution was subjected to degassing by an aspirator. 140 µl of 10% ammonium persulfate and 12 µl of TEMED (N,N,N',N'-tetramethylenediamine) were added to the resolving gel solution and then the separating gel solution was poured into the gap between the glass plates. Water saturated n-butanol was gently overlayed onto the surface of the gel solution and the gel was left standing until it was polymerized. In the meantime, a stacking gel solution was prepared. 1.8 ml of solution A, 3 ml of solution C (0.5 M Tris-HCl/pH 6.8, 0.4% SDS) and 7.2 ml of distilled water were combined and the stacking gel solution was subjected to degassing. 36 µl of 10% ammonium persulfate and 12 µl of TEMED (N,N,N',N'-tetramethylenediamine) were added to the stacking gel solution and the stacking gel solution was mixed well. When the resolving gel solution was polymerized, the n-butanol overlay was gently discarded. The stacking gel solution was poured directly onto the resolving gel and then a comb was inserted into the stacking gel solution. When the stacking gel solution was polymerized, the gel was placed in an electphoresis apparatus. Both upper and lower buffer reservors were filled with electrophoresis buffer (0.025M Tris-HCl, 0.192M glycine, 0.1% SDS). 1/3 volume of sample buffer (0.25 M Tris-HCl, 4% mercaptoethanol, 8% SDS, 40% glycerol) was added to the crude extract (20 µg of protain). The mixture was heated at 90°C for 5 minutes and then placed in the wells of the plate. Electrophoresis was carried out at 10 mA for 12 - 15 hours. After electrophoresis, half of the gel was stained to detect proteins and another half was used for Western blotting.
0048Coomassie Brilliant Blue (CBB) staining: The gel was immersed in a staining solution (0.25% CBB in a 5:1:5 water/acetic acid/methanol solution) and shaked at room temperature for one hour. The staining solution was decanted. The gel was rinsed with water briefly and washed in a 8:1:1 water/methanol/acetic acid solution at room temperature for 24 hours.
0049Western blotting: Antibody of a rabbit serum specific to nitrile hydratase purified from <i>Rhodococcus</i> sp. N-774 was used as a primary antibody. The proteins on the gel were transferred to a transfer membrane [Poly(vinylidene difluoride), Millipore] using zaltoblot 2-SM17556. The transfer was carried out at 4 mA/cm<sup>2</sup> for 15 minutes. The transfer membrane was soaked in 100 ml of TBS containing 3 g of heat dissolved gelatine. The membrane was incubated with shaking at room temperature for one hour. The membrane was then transferred to 100 ml of TBS solution containing 1% gelatine. 20 µl of the primary antibody was added to the solution and the membrane was incubated with shaking at room temperature for 2 hours. After incubation, the membrane was washed 2 times with TBS and then placed in 100 ml of TBS containing 1% gelatine. 50 µl of a secondary antibody, goat anti-rabbit IgG horseradish peroxidase (GAR-HRP)[Bio-Rad], was added to the TBS. The membrane was incubated with shaking at room tempeture for 2 hours. The membrane was washed with distilled water and then 2 times with TBS. The membrane was placed in 100 ml of TBS containing 60 µl of H<sub>2</sub>O<sub>2</sub> in a vessel. 60 mg of a HRP color development reagent (Bio-Rad) dissolved in 20 ml of ice cold methanol was added to the vessel. When the band appeared on the membrane, the membrane was washed with distilled water and dried.
0050Almost no nitrile hydratrase band was found on the gel stained by CBB. However in the ATCC12674/pKRNH2 lane and the ATCC12674/pAKR325 lane on the gel of Western blotting, bands resulting from the binding of the antibody to nitrile hydratase were found at the same position as the one of the band of nitrile hydratase obtained from <i>Rhodococcus sp.</i> N-774. In contrast, there was no band found in the control lane (<i>Rhodococcus rhodochrous</i>/pK4). ATCC12674/pKRNH2 and ATCC12674/pAKR325 were found to express the nitrile hydratase gene derived from <i>Rhodococcus sp.</i> N-774.
(4) - (ii) Photoactivation of Nitrile Hydratase
0051Nitrile hydratase of <i>Rhodococcus sp.</i> N-774 is known to be activated by light illumination while the photoactivation of the nitrile hydratse of <i>Rhodococcus rhodochrous</i> ATCC 12674 is not known. It is possible to confirm that whether ATCC12674/pKRNH2 and ATCC12674/pAKR325 express the nitrile hydratase gene derived from <i>Rhodococcus sp.</i> N-774 by the photoactivation.
005210 ml of an MY-glycerol medium was placed in a test tube and the tube was autoclaved. ATCC12674/pk4, ATCC12674/pKRNH2 and ATCC12674/pAKR325 were placed in a separate tube and grown without exposing to light (the tube was wrapped by alminum foil) or under the exposure to light. Both cultures were incubated with shaking at 26°C for 36 hours. After incubation, the nitrile hydratase activity was determined. The bacterial cells grown under dark conditions were kept manipulating only in dark conditions: centrifugation was carried out under a weak red light in the darkroom. ATCC12674/pK4 (control) did not show a photoactivation while ATCC12674/pKRNH2 and ATCC12674/pAKR325 increased an activity, under the exposure to light. The result suggested that ATCC12674/pKRNH2 and ATCC12674/pAKR325 produced an enzyme having a photoactivation shown by <i>Rhodococcus sp.</i> N-774. <tables id="tabl0007" num="0007"><table frame="all"><title>Table 4</title><tgroup cols="5" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="31.50mm" /><colspec colnum="2" colname="col2" colwidth="31.50mm" /><colspec colnum="3" colname="col3" colwidth="31.50mm" /><colspec colnum="4" colname="col4" colwidth="31.50mm" /><colspec colnum="5" colname="col5" colwidth="31.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col5" align="center">Photoactivation of Nitrile hydratase</entry></row><row><entry namest="col1" nameend="col1" rowsep="0" align="center">Bacterial Strain/Plasmid</entry><entry namest="col2" nameend="col3" align="center">Dark conditions</entry><entry namest="col4" nameend="col5" align="center">Light conditions</entry></row><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="center">Growth (OD<sub>630</sub>)</entry><entry namest="col3" nameend="col3" align="center">Specific Activity (U/mg cell)</entry><entry namest="col4" nameend="col4" align="center">Growth (OD<sub>630</sub>)</entry><entry namest="col5" nameend="col5" align="center">Specific Activity (U/mg cell)</entry></row></thead><tbody valign="top"><row rowsep="0"><entry namest="col1" nameend="col1" align="left">ATCC 12674 /pK4</entry><entry namest="col2" nameend="col2" align="right">9.0</entry><entry namest="col3" nameend="col3" align="char" char=".">1.2</entry><entry namest="col4" nameend="col4" align="right">6.5</entry><entry namest="col5" nameend="col5" align="right">1.4</entry></row><row rowsep="0"><entry namest="col1" nameend="col1" align="left">ATCC 12674 /pKRNH2</entry><entry namest="col2" nameend="col2" align="right">0.08</entry><entry namest="col3" nameend="col3" align="char" char=".">96.8</entry><entry namest="col4" nameend="col4" align="right">0.18</entry><entry namest="col5" nameend="col5" align="right">193</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">ATCC 12674 /pAKR325</entry><entry namest="col2" nameend="col2" align="right">14.5</entry><entry namest="col3" nameend="col3" align="char" char=".">0.3</entry><entry namest="col4" nameend="col4" align="right">13.8</entry><entry namest="col5" nameend="col5" align="right">1.7</entry></row></tbody></tgroup></table></tables>
Example 4.
Production of Amides Using Transformants
0053<i>Rhodococcus rhodochrous</i> ATCC 12674/pKRNH2 (hereafter referred to as ATCC 12674/pKRNH2) was grown in 10 ml of an MYP medium (1% glycerol, 0.5% polypeptone, 0.3% yeast extract, 0.3% malt extract, 0.05% potassium dihydrogenphosphate, 0.05% dipotassium hydrogenphosphate, 50 µg/ml of kanamycin) in the presence of a given amount of methacrylamide, an inducer for nitrile hydratase, or in the absence of the inducer agent, under the fluorescent light at 25°C for 24 - 48 hours. <i>Rhodococcus rhodochrous</i> ATCC 12674/pK4 (hereafter referred to as ATCC 12674/pK4) used as a control was also grown under the same culture conditions. Bacterial cells were harvested by centrifugation, washed with 50 mM phosphate buffer/pH7.7 and resuspended in 1 ml of 50 mM phosphate buffer/pH7.7. The suspension was placed on ice under the fluorescent light for one hour. 100 µl of the suspension and 0.8 ml of 50 mM phophate buffer were combined and the mixture was then incubated at 20°C for 10 minutes. After incubation, 10 µl of 1 M acrylonitrile was added to the mixture, which was then incubated for 10 minutes. 200 µl of 1N-HCl was added to the mixture to stop the reaction. A nitrile hydratase activity was determined by measuring an amount of acrylonitrile and acrylamide in the reaction mixture using gas chromatography. Table 5 shows the nitrile hydratase activity of ATCC12674/pKRNH2 and the control. <tables id="tabl0008" num="0008"><table frame="all"><title>Table 5</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col4" align="center">Nitrile hydratase activity</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Bacterial Strain/ Plasmid</entry><entry namest="col2" nameend="col2" align="left">Methacrylamide</entry><entry namest="col3" nameend="col3" align="left">Growth (OD<sub>630</sub>)</entry><entry namest="col4" nameend="col4" align="left">Specific Activity (U/mg cell)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">ATCC</entry><entry namest="col2" nameend="col2" align="left">0</entry><entry namest="col3" nameend="col3" align="char" char=".">3.2</entry><entry namest="col4" nameend="col4" align="right">trace</entry></row><row><entry namest="col1" nameend="col1" align="left">12674</entry><entry namest="col2" nameend="col2" align="left">0.1</entry><entry namest="col3" nameend="col3" align="char" char=".">3.1</entry><entry namest="col4" nameend="col4" align="right">3.2</entry></row><row><entry namest="col1" nameend="col1" align="left">/pK4</entry><entry namest="col2" nameend="col2" align="left">0.2</entry><entry namest="col3" nameend="col3" align="char" char=".">3.6</entry><entry namest="col4" nameend="col4" align="right">9.1</entry></row><row><entry namest="col1" nameend="col1" /></row><row><entry namest="col1" nameend="col1" align="left">ATCC</entry><entry namest="col2" nameend="col2" align="left">0</entry><entry namest="col3" nameend="col3" align="char" char=".">2.7</entry><entry namest="col4" nameend="col4" align="right">12.1</entry></row><row><entry namest="col1" nameend="col1" align="left">12674</entry><entry namest="col2" nameend="col2" align="left">0.1</entry><entry namest="col3" nameend="col3" align="char" char=".">2.5</entry><entry namest="col4" nameend="col4" align="right">45.0</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">/pKRNH2</entry><entry namest="col2" nameend="col2" align="left">0.2</entry><entry namest="col3" nameend="col3" align="char" char=".">2.1</entry><entry namest="col4" nameend="col4" align="right">152.3</entry></row></tbody></tgroup></table></tables>
Example 5
Production of Acids Using Transformants
0054<i>Rhodococcus rhodochrous</i> ATCC 12674/pKRNH2 (hereafter referred to as ATCC 12674/pKRNH2) was grown in 10 ml of an MYP medium (1% glycerol, 0.5% polypeptone, 0.3% yeast extract, 0.3% malt extract, 0.05% potassium dihydrogenphosphate, 0.05% dipotassium hydrogenphosphate 50 µg/ml of kanamycin) in the presence of a given amount of methacrylamide, an inducer for amidase, or in the absence of the inducer, under the fluorescent light at 25°C for 24 - 48 hours. <i>Rhodococcus rhodochrous</i> ATCC 12674/pK4 (hereafter referred to as ATCC 12674/pK4) used as a control was also grown under the same culture conditions. Bacterial cells were harvested by centrifugation, washed with 50 mM phosphate buffer/pH7.7 and resuspended in 1 ml of 50 mM phosphate buffer/pH7.7. The suspension was incubated on ice under the fluorescent light for one hour. 100 µl of the suspension and 0.8 ml of 50 mM phophate buffer were combined and the mixture was then incubated at 20°C for 10 minutes. After incubation, 100 µl of 1 M propionamide was added to the mixture, which was then incubated for 1 hour. 200 µl of 1N-HCl was added to the mixture to stop the reaction. An amidase activity was determined by measuring an amount of propionamide and propionic acid in the reaction mixture using gas chromatography. Table 6 shows the amidase activity of ATCC12674/pKRNH2 and the control. <tables id="tabl0009" num="0009"><table frame="all"><title>Table 6</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col4" align="center">amidase activity</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="center">Bacterial Strain/Plasmid</entry><entry namest="col2" nameend="col2" align="center">Methacrylamide</entry><entry namest="col3" nameend="col3" align="center">Growth (OD<sub>630</sub>)</entry><entry namest="col4" nameend="col4" align="center">Specific Activity (U/mg cell)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" morerows="2" align="left">ATCC 12674 /pK4</entry><entry namest="col2" nameend="col2" align="char" char=".">0</entry><entry namest="col3" nameend="col3" align="char" char=".">3.2</entry><entry namest="col4" nameend="col4" align="char" char=".">0.03</entry></row><row><entry namest="col2" nameend="col2" align="char" char=".">0.1</entry><entry namest="col3" nameend="col3" align="char" char=".">3.1</entry><entry namest="col4" nameend="col4" align="char" char=".">0.04</entry></row><row><entry namest="col2" nameend="col2" align="char" char=".">0.2</entry><entry namest="col3" nameend="col3" align="char" char=".">3.6</entry><entry namest="col4" nameend="col4" align="char" char=".">0.05</entry></row><row><entry namest="col1" nameend="col1" morerows="2" rowsep="1" align="left">ATCC 12674 /pKRNH2</entry><entry namest="col2" nameend="col2" align="char" char=".">0</entry><entry namest="col3" nameend="col3" align="char" char=".">2.7</entry><entry namest="col4" nameend="col4" align="char" char=".">0.10</entry></row><row><entry namest="col2" nameend="col2" align="char" char=".">0.1</entry><entry namest="col3" nameend="col3" align="char" char=".">2.5</entry><entry namest="col4" nameend="col4" align="char" char=".">0.50</entry></row><row rowsep="1"><entry namest="col2" nameend="col2" align="char" char=".">0.2</entry><entry namest="col3" nameend="col3" align="char" char=".">2.1</entry><entry namest="col4" nameend="col4" align="char" char=".">1.49</entry></row></tbody></tgroup></table></tables>
5 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0445646A | Cites | European Patent Office (EPO) | – |
| WO8907151A | Cites | World Intellectual Property Organization (WIPO) | – |
| FR2633938A | Cites | France | – |
| US4920054A | Cites | United States of America | – |
| Inoue et al. (1990), Gene, 96, p.23-28. | Non-patent | – | Examiner |
| Ikehata et al. (1989), Eur. J. Biochem., 181, p. 563-570. | Non-patent | – | Examiner |
| Hanahan (1983), J. Mol. Biol., 166, p.557-580. | Non-patent | – | Examiner |
| Inoue et al. (1990), Gene, 96, p.23-28. | Non-patent | – | – |
| Ikehata et al. (1989), Eur. J. Biochem., 181, p. 563-570. | Non-patent | – | – |
| Hanahan (1983), J. Mol. Biol., 166, p.557-580. | Non-patent | – | – |
10 members in 4 offices; this record represents the family
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 3754491 | Japan | A | |
| 3754591 | Japan | A | |
| 3754491 | Japan | – | |
| 3754591 | Japan | – | |
| JP19910037544 | – | – | – |
| JP19910037545 | – | – | – |
| 3754491 | – | – | – |
| 3754591 | – | – | – |
Members10
| Document | Office | Kind | |
|---|---|---|---|
| EP0502476A2 | European Patent Office (EPO) | A2 | |
| JPH0564589A | Japan | A | |
| JPH0568566A | Japan | A | |
| EP0502476A3 | European Patent Office (EPO) | A3 | |
| US5654180A | United States of America | A | |
| JP3142348B2 | Japan | B2 | |
| JP3142349B2 | Japan | B2 | |
| EP0502476B1This record | European Patent Office (EPO) | B1 | |
| DE69231939D1 | Germany | D1 | |
| DE69231939T2 | Germany | T2 |
31 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Expiry of rightR071 | R071 | DE | |
| Expiry of rightR071 | R071 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Information provided on ipc code assigned before grant7C 12N 15/74 A, 7C 12N 15/70 B, 7C 12N 15/55 B, 7C 12N 1/21 BRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0502476
- Publication, DOCDB
- 0502476
- Publication, EPODOC
- EP0502476
- Application
- 92103610
- Application, DOCDB
- 92103610
- Application, EPODOC
- EP19920103610
Titles3
- German
- Hybrid-Plasmid-Vektoren, die für Nitril-abbauende Enzyme kodierende Gene enthalten und Verfahren zur Herstellung von Amiden und Säuren
- English
- Hybrid plasmid vectors containing genes encoding nitrile degrading enzymes and methods of producing amides and acids
- French
- Vecteurs plasmidiques hybrides contenant des gènes codant pour des enzymes qui dégradent des nitriles et procédés por la préparation d'amides et d'acides
Classification
- CPC, 2
- C12N15/74
- C12N9/78
- IPC, 4
- C12N1 21
- C12N9 78
- C12N15 55
- C12N15 74
Designated states3
- Contracting states, 3
- Germany
- France
- United Kingdom
